Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-26 5:05 pm Sale | 2023-06-22 | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% | -13,000,000 (-14.73%) | Filing History |
| 2023-02-14 5:20 pm Purchase | 2022-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Vivek Ramaswamy | 81,783,241 10.900% | 7,381,272 (+9.92%) | Filing History |
| 2023-02-14 4:08 pm Purchase | 2022-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Dexcel Pharma Technologies Ltd. | 102,849,443 14.150% | 4,040,285 (+4.09%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | SB Investment Advisers (UK) Limited | 95,031,667 13.100% | -4,343,919 (-4.37%) | Filing History |
| 2023-02-14 11:46 am Sale | 2022-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | QVT Financial LP | 122,541,536 16.890% | -6,852,281 (-5.30%) | Filing History |
| 2023-02-03 4:30 pm Unchanged | 2022-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Sumitomo Chemical Co. Ltd. | 86,367,360 11.910% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 88,238,700 12.800% | 88,238,700 (New Position) | Filing History |
| 2022-02-14 4:01 pm Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Vivek Ramaswamy | 74,401,969 10.500% | 74,401,969 (New Position) | Filing History |
| 2022-02-14 3:00 pm Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | QVT Financial LP | 129,393,817 18.700% | 129,393,817 (New Position) | Filing History |
| 2022-02-14 09:57 am Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | SB Investment Advisers (UK) Limited | 99,375,586 14.400% | 99,375,586 (New Position) | Filing History |
| 2022-02-10 4:26 pm Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Dexcel Pharma Technologies Ltd. | 98,809,158 14.280% | 98,809,158 (New Position) | Filing History |
| 2022-02-01 4:06 pm Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Sumitomo Chemical Co. Ltd. | 86,367,360 12.480% | 86,367,360 (New Position) | Filing History |
| 2021-10-20 5:13 pm Purchase | 2021-10-18 | 13D | ARBUTUS BIOPHARMA CORP ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 29.100% | 22,833,922 (+142.59%) | Filing History |